Standardised mortality ratios for the 1988–2008 time period
| Cause of death | Observed | Expected | SMR | 95% CI* |
|---|---|---|---|---|
| All deaths | 407 | 478.1 | 0.85 | 0.77 to 0.94 |
| Coronary heart disease | 104 | 123.7 | 0.84 | 0.69 to 1.02 |
| Respiratory disease (not COPD) | 12 | 29.8 | 0.40 | 0.21 to 0.70 |
| COPD | 18 | 23.2 | 0.78 | 0.46 to 1.23 |
| Infectious disease (excluding AIDS) | 3 | 4.0 | 0.75 | 0.15 to 2.22 |
| Accidents and suicide | 27 | 31.9 | 0.85 | 0.56 to 1.23 |
| Accidents | 11 | 20.8 | 0.53 | 0.26 to 0.95 |
| Suicide | 16 | 11.2 | 1.43 | 0.82 to 2.33 |
| All cancer deaths | 159 | 173.5 | 0.92 | 0.78 to 1.07 |
| All other causes of death | 84 | 92.0 | 0.91 | 0.73 to 1.13 |
| Select cancer sites | ||||
| Prostate cancer | 13 | 12.6 | 1.03 | 0.55 to 1.76 |
| Lung cancer | 50 | 43.6 | 1.15 | 0.85 to 1.51 |
| Stomach | 9 | 7.1 | 1.27 | 0.58 to 2.42 |
| Pancreas | 5 | 7.5 | 0.67 | 0.22 to 1.56 |
| Colorectal cancer | 20 | 19.2 | 1.04 | 0.64 to 1.61 |
| Head and neck* | 11 | 5.0 | 2.20 | 1.09 to 3.93 |
| Oral cavity, pharynx and larynx† | 11 | 5.2 | 2.13 | 1.06 to 3.81 |
| Larynx | 2 | 1.0 | 2.00 | 0.23 to 7.39 |
| Melanoma | 4 | 7.2 | 0.56 | 0.15 to 1.42 |
| Multiple myeloma | 5 | 3.2 | 1.58 | 0.51 to 3.69 |
| Hodgkin disease | 1 | 0.4 | 2.30 | 0.03 to 12.8 |
| NHL | 3 | 7.0 | 0.43 | 0.09 to 1.25 |
| All leukaemia | 4 | 5.6 | 0.71 | 0.19 to 1.83 |
| Non-lymphoid leukaemia | 3 | 3.8 | 0.78 | 0.16 to 2.28 |
| Lymphoid leukaemia | 1 | 1.8 | 0.57 | 0.01 to 3.16 |
| All other cancers‡ | 34 | 54.9 | 0.62 | 0.43 to 0.87 |
COPD, chronic obstructive pulmonary disease;NHL, non-Hodgkin lymphoma; SMR, standardised mortality ratios.
*Excludes cancer of the larynx or oesophagus.
†Head and neck without cancer of the lip, sinus cavities or salivary glands, but includes cancer of the larynx.
‡All cancer except; lung, prostate, stomach, pancreas, colon and rectum, oral cavity, pharynx, larynx, melanoma, multiple myeloma, Hodgkin disease, non-Hodgkin lymphoma, and all leukaemia.